Kestra Medical Technologies, Ltd. (KMTS) Balance Sheet
KMTS balance sheet, FY2026
April 30, 2026 · U.S. dollars$358.5M assets = $98.8M liabilities + $259.7M equity
Both columns are drawn to the same scale: what KMTS owns equals what it owes plus shareholders’ equity. Hover a block for its value.
KMTS financial health
Descriptive bands, not a rating. Fiscal FY2026.
KMTS balance sheet trends, FY2020–FY2026
| Metric | Trend | Then | Latest | Change |
|---|---|---|---|---|
| Total assets | $7.9MFY2020 | $358.5MFY2026 | +114.6%/yr | |
| Total liabilities | $4.0MFY2020 | $98.8MFY2026 | +89.8%/yr | |
| Shareholders’ equity | $3.9MFY2020 | $259.7MFY2026 | +132.1%/yr | |
| Cash & short-term investments | $5.8MFY2020 | $196.4MFY2026 | +102.6%/yr | |
| Total debt | $452,000FY2020 | $46.8MFY2026 | +152.9%/yr | |
| Net cash (debt) | $5.3MFY2020 | $149.6MFY2026 | +$144.3M | |
| Working capital | $2.2MFY2020 | $172.0MFY2026 | +$169.8M | |
| Book value per share | $0.08FY2020 | $4.45FY2026 | +124.6%/yr | |
| Current ratio | 1.54FY2020 | 4.41FY2026 | +2.88 | |
| Debt / equity | 0.12FY2020 | 0.18FY2026 | +0.06 | |
| Shares outstanding | 49.5MFY2020 | 58.4MFY2026 | +3.3%/yr |
Change is the average annual growth (CAGR) or the difference between the first and latest year.
KMTS assets
KMTS liabilities and equity
KMTS debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease obligations.
KMTS balance sheet
| FY2026 | FY2025 | FY2024 | FY2023 | FY2021 | FY2020 | |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Cash & short-term investments | $196.4M | $237.6M | $8.2M | $14.8M | $24.3M | $5.8M |
| Cash & equivalents | $99.7M | $237.6M | $8.2M | $14.8M | $24.3M | $5.8M |
| Short-term investments | $96.7M | $0 | — | — | — | — |
| Receivables | $14.5M | $8.1M | $2.0M | $2.1M | $0 | $0 |
| Inventory | $6.7M | $6.6M | $3.3M | $2.1M | $0 | $0 |
| Other current assets | $4.7M | $3.1M | $1.4M | $0 | $1.9M | $412,000 |
| Total current assets | $222.4M | $255.3M | $14.9M | $18.4M | $26.2M | $6.2M |
| Property, plant & equipment (net) | $62.5M | $36.9M | $28.4M | $16.7M | $3.1M | $1.1M |
| Goodwill & intangible assets | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-term investments | $65.8M | $0 | $0 | $0 | $0 | $0 |
| Other non-current assets | $7.9M | $3.5M | $2.7M | $3.5M | $1.2M | $580,000 |
| Total assets | $358.5M | $295.7M | $45.9M | $38.7M | $30.5M | $7.9M |
| Liabilities | ||||||
| Accounts payable | $27.3M | $24.0M | $23.9M | $6.2M | $1.7M | $1.8M |
| Short-term debt | $31,000 | $187,000 | — | $21.8M | $1.1M | $452,000 |
| Total current liabilities | $50.4M | $38.0M | $33.0M | $36.7M | $6.6M | $4.0M |
| Long-term debt | $42.6M | $41.1M | $42.5M | $17.3M | $20.2M | $0 |
| Lease obligations | $4.1M | $3.2M | $2.6M | $1.4M | $2.6M | $452,000 |
| Other long-term liabilities | $5.8M | $11.3M | $179.8M | $102.2M | $1.9M | $0 |
| Total liabilities | $98.8M | $90.3M | $255.3M | $156.2M | $28.8M | $4.0M |
| Shareholders' equity | ||||||
| Common stock & paid-in capital | $58.4M | $51.3M | $1,000 | $1,000 | $1,000 | $1,000 |
| Retained earnings (deficit) | −$651.9M | −$520.2M | −$406.4M | −$312.3M | −$170.1M | −$136.0M |
| Accumulated other comprehensive income | −$218,000 | — | — | — | — | — |
| Total shareholders' equity | $259.7M | $205.4M | −$209.4M | −$117.6M | $1.8M | $3.9M |
| Key figures | ||||||
| Total debt | $46.8M | $44.3M | $45.2M | $39.1M | $22.8M | $452,000 |
| Net cash (debt) | $149.6M | $193.3M | −$36.9M | −$24.3M | $1.5M | $5.3M |
| Working capital | $172.0M | $217.4M | −$18.1M | −$18.3M | $19.6M | $2.2M |
| Tangible book value | $259.7M | $205.4M | −$209.4M | −$117.6M | $1.8M | $3.9M |
| Book value per share | $4.45 | $4.15 | −$4.23 | −$5.91 | $0.04 | $0.08 |
| Shares outstanding | 58.4M | 49.5M | 49.5M | 19.9M | 49.5M | 49.5M |
| Current ratio | 4.41 | 6.72 | 0.45 | 0.50 | 3.96 | 1.54 |
| Quick ratio | 4.19 | 6.47 | 0.31 | 0.46 | 3.68 | 1.43 |
| Debt / equity | 0.18 | 0.22 | — | — | 12.94 | 0.12 |
| Equity / assets | 72.4% | 69.5% | −455.7% | −304.2% | 5.8% | 49.0% |
| Jul '26 | Apr '26 | Jan '26 | Oct '25 | Jul '25 | Apr '25 | Jan '25 | Oct '24 | Apr '24 | Jul '21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Cash & short-term investments | $198.9M | $196.4M | $291.3M | $175.4M | $201.2M | $237.6M | $54.4M | $76.9M | $8.2M | $11.1M |
| Cash & equivalents | $68.6M | $99.7M | $291.3M | $175.4M | $201.2M | $237.6M | $54.4M | $76.9M | $8.2M | $11.1M |
| Short-term investments | $130.4M | $96.7M | — | — | — | $0 | — | — | — | — |
| Receivables | $15.4M | $14.5M | $12.7M | $10.4M | $9.2M | $8.1M | $7.9M | $5.4M | $2.0M | $0 |
| Inventory | $7.4M | $6.7M | $6.8M | $6.9M | $6.8M | $6.6M | $6.0M | $4.3M | $3.3M | $0 |
| Other current assets | $4.5M | $4.7M | $3.2M | $2.7M | $3.4M | $3.1M | $1.6M | $1.3M | $1.4M | $2.5M |
| Total current assets | $226.3M | $222.4M | $314.1M | $195.4M | $220.7M | $255.3M | $69.9M | $87.9M | $14.9M | $13.6M |
| Property, plant & equipment (net) | $66.9M | $62.5M | $57.2M | $47.9M | $42.4M | $36.9M | $33.3M | $31.0M | $28.4M | $2.9M |
| Goodwill & intangible assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-term investments | $45.8M | $65.8M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other non-current assets | $8.4M | $7.9M | $8.1M | $3.4M | $3.2M | $3.5M | $4.7M | $2.5M | $2.7M | $3.0M |
| Total assets | $347.4M | $358.5M | $379.3M | $246.7M | $266.3M | $295.7M | $108.0M | $121.5M | $45.9M | $19.5M |
| Liabilities | ||||||||||
| Accounts payable | $26.0M | $27.3M | $24.0M | $20.2M | $18.6M | $24.0M | $25.7M | $20.2M | $23.9M | $2.0M |
| Short-term debt | $23,000 | $31,000 | $10,000 | $53,000 | $36,000 | $187,000 | — | — | — | $797,000 |
| Deferred revenue | — | — | — | — | — | — | $460,000 | $330,000 | — | — |
| Total current liabilities | $48.3M | $50.4M | $42.9M | $35.8M | $32.3M | $38.0M | $38.7M | $31.3M | $33.0M | $6.8M |
| Long-term debt | $72.5M | $42.6M | $42.3M | $41.9M | $41.5M | $41.1M | $43.7M | $43.3M | $42.5M | $0 |
| Lease obligations | $4.0M | $4.1M | $4.3M | $2.9M | $3.1M | $3.2M | $2.9M | $2.8M | $2.6M | — |
| Other long-term liabilities | $4.2M | $5.8M | $6.2M | $5.0M | $8.4M | $11.3M | $283.4M | $283.3M | $179.8M | $23.0M |
| Total liabilities | $125.0M | $98.8M | $91.4M | $82.6M | $82.1M | $90.3M | $365.9M | $358.0M | $255.3M | $29.8M |
| Shareholders' equity | ||||||||||
| Common stock & paid-in capital | $59.3M | $58.4M | $58.3M | $51.4M | $51.3M | $51.3M | $1,000 | $1,000 | $1,000 | $1,000 |
| Retained earnings (deficit) | −$695.9M | −$651.9M | −$613.0M | −$578.9M | −$546.1M | −$520.2M | −$468.2M | −$446.7M | −$406.4M | −$183.2M |
| Accumulated other comprehensive income | −$471,000 | −$218,000 | — | — | — | — | — | — | — | — |
| Total shareholders' equity | $222.4M | $259.7M | $288.0M | $164.1M | $184.2M | $205.4M | −$274.1M | −$253.0M | −$209.4M | −$10.3M |
| Key figures | ||||||||||
| Total debt | $76.4M | $46.8M | $46.5M | $44.8M | $44.6M | $44.3M | $46.6M | $46.1M | $45.2M | $23.5M |
| Net cash (debt) | $122.5M | $149.6M | $244.8M | $130.6M | $156.6M | $193.3M | $7.7M | $30.8M | −$36.9M | −$12.4M |
| Working capital | $178.0M | $172.0M | $271.1M | $159.7M | $188.4M | $217.4M | $31.2M | $56.6M | −$18.1M | $6.8M |
| Tangible book value | $222.4M | $259.7M | $288.0M | $164.1M | $184.2M | $205.4M | −$274.1M | −$253.0M | −$209.4M | −$10.3M |
| Book value per share | $3.80 | $4.45 | $5.45 | $3.19 | $3.59 | $4.15 | −$5.53 | −$5.11 | −$4.23 | −$0.21 |
| Shares outstanding | 58.6M | 58.4M | 52.8M | 51.4M | 51.3M | 49.5M | 49.5M | 49.5M | 49.5M | 49.5M |
| Current ratio | 4.69 | 4.41 | 7.32 | 5.47 | 6.84 | 6.72 | 1.81 | 2.81 | 0.45 | 2.00 |
| Quick ratio | 4.44 | 4.19 | 7.08 | 5.20 | 6.52 | 6.47 | 1.61 | 2.63 | 0.31 | 1.63 |
| Debt / equity | 0.34 | 0.18 | 0.16 | 0.27 | 0.24 | 0.22 | — | — | — | — |
| Equity / assets | 64.0% | 72.4% | 75.9% | 66.5% | 69.2% | 69.5% | −253.8% | −208.3% | −455.7% | −52.9% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed July 14, 2026); data from EODHD.
KMTS financial position
At the end of fiscal 2026 (April 30, 2026), Kestra Medical Technologies had total assets of $358.5 million (up 21.2% from a year earlier), total liabilities of $98.8 million and shareholders' equity of $259.7 million. It held $196.4 million in cash and short-term investments against $46.8 million of debt, a net cash position of $149.6 million. Its current ratio was 4.41. In the latest quarter (ended July 31, 2026) total assets were $347.4 million and equity $222.4 million.
Related: KMTS income statement, KMTS cash flow statement, KMTS key metrics. See the KMTS stock overview for the latest quote and news.
KMTS balance sheet FAQ
What are Kestra Medical Technologies's total assets?
Kestra Medical Technologies reported total assets of $358.5 million at the end of fiscal 2026 (April 30, 2026), compared with $295.7 million a year earlier.
How much debt does Kestra Medical Technologies have?
Kestra Medical Technologies had $46.8 million of total debt at the end of fiscal 2026, including short-term borrowings and lease obligations. Its debt-to-equity ratio was 0.18.
How much cash does Kestra Medical Technologies have?
Kestra Medical Technologies held $196.4 million in cash and short-term investments at the end of fiscal 2026; with $46.8 million of debt that is net cash of $149.6 million.
What is Kestra Medical Technologies's book value?
Kestra Medical Technologies's shareholders' equity (book value) was $259.7 million at the end of fiscal 2026, or $4.45 per share.
What is Kestra Medical Technologies's current ratio?
Kestra Medical Technologies had current assets of $222.4 million and current liabilities of $50.4 million, a current ratio of 4.41 (it can cover its short-term obligations).